| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |